The "Biology" category is flooded with 1-unit labs and student projects. Our AI agents verify clinical trial phases (IND/Phase I-III), bioreactor capacity, and patent depth to find verified Therapeutic Startups, Gene Therapy Labs, and CDMOs.
Why firmographic filters miss the high-CAPEX buyers.
Targeting "Life Sciences" tells you nothing about a company's ability to buy high-ticket instrumentation. You need to know what they synthesize and how they scale.
If you are selling bioreactors, HPLC systems, or clinical data APIs, you need the builders:
| Metric | Standard "Science" List | Our ICP Database |
|---|---|---|
| Classification | Broad (NAICS 5417) | Therapeutic vs. Platform vs. CDMO |
| Tech Signals | None | Bioreactor & LIMS Verification |
| Buying Center | Lab Manager | CTO / Head of Clinical Ops |
| Clinical | Unknown | IND / Phase I-III Status Match |
Target builders of the future of human health.
Pre-clinical/Phase I firms. Targets for lab-sharing services, R&D chemicals, and specialized legal.
CRISPR and viral vector innovators. Targets for genome data APIs, cleanroom gear, and sub-micron testing.
Manufacturing for others. Targets for bioreactors, process control, and FDA validation data.
Generative AI for molecule design. Targets for GPU clusters, vector databases, and chemical datasets.
Focus on rare diseases. Targets for specialized clinical trial networks and patient data APIs.
Focus on gut/skin health. Targets for sequencing services, anaerobe chambers, and bio-data tools.
Infectious disease focus. Targets for secure cloud, government grants, and high-security staffing.
Software for sequence analysis. B2B targets for API data and cloud orchestration.
Building peptides/oligonucleotides. Targets for HPLC hardware, solvents, and B2B portals.
Investing in BioTech assets. Targets for due diligence and deal-flow data.
Translating campus research. Targets for IP management and student data.
Transdermal and implantable tech. Targets for mechanical engineering and FDA legal.
Ginkgo/Zymergen clones. Targets for DNA synthesis partners and automation robotics.
Handling FDA filings. Targets for document management and data research.
Moving live tissue/cells. Targets for IoT sensors and specialized containers.
Cryo-EM and super-res microscopy. Targets for massive storage and high-end cameras.
Bio-fuels and green chemicals. Targets for industrial kilns and feedstock logistics.
Liquid handling mfgs. Targets for motor hardware and firmware dev data.
Patient data analytics SaaS. Targets for EMR data feeds and secure cloud.
Specialized storytelling. Targets for influencer databases and event data.
In BioTech, the "Pipeline Stage" determines the enterprise value. A company with a public Phase II Trial and proprietary IND (Investigational New Drug) status is a top-tier account.
We extract these "Scientific Signals" to help you find the builders.
If you sell quality management software, filter for startups with Phase I data but no "QMS" or "eTMF" mention.
Pitch: "Avoid clinical delays by automating your GLP/GCP documentation directly from your lab bench..."
We distinguish between companies that do science and companies that do business.
This ensures you pitch to actual manufacturers, not just theoretical research groups.
Get the data that powers the global BioTech ecosystem.